NCT06211010View on ClinicalTrials.gov

The Target Urine VOCs Biosensor for Genitourinary Malignancy Detection

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

November 1, 2023

Conditions
The Phenomenon of the Decrease in the Electrical Resistance Within the Conducting Chambers, Making the Increase in a Conducting Property
Interventions
DIAGNOSTIC_TEST

the semiconductor metal oxide sensors.

The method of analyzing the VOCs was through analyzing the evaporated VOCs from the urine in the container when they evaporated into the sealed chamber. The VOCs in the chamber were then analyzed at the same time by the five different gas semiconductor sensors which were located on the top of the chamber.

Trial Locations (1)

30000

Institute of Medicine, Suranaree University of Technology, Nakhon Ratchasima

All Listed Sponsors
lead

Suranaree University of Technology

OTHER

NCT06211010 - The Target Urine VOCs Biosensor for Genitourinary Malignancy Detection | Biotech Hunter | Biotech Hunter